Cueni LN, Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease[J]. J Invest Dermatol, 2006, 126(10): 2167-2177.
[3]
Des Guetz G, Uzzan B, Nicolas P, et al. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta analysis of the literature[J]. Br J Cancer, 2006, 94(12):1823-1832.
[4]
Alabi AA, Suppiah A, Madden LA, et al. Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients[J]. Int J Colorectal Dis, 2009, 24(3): 269-274.
[5]
George G, Chen HX, Janet FY, et al. 15 - hydroxy - eicosate traenoic acid arrests growth of colorectal cancer cells via aperoxisome poliferator-activated receptor gamma depengent pathway[J]. Intern J Cancer, 2003, 107(5): 837-843.
[6]
Pandhare J, Cooper SK, Phang JM. Proline Oxidase, a p roapop toticgene is induced by troglitazone: Evidence for both PPAR - dependent and independ - entmechanisms[J]. J Biol Chem, 2006, 281(4): 2044-2052.
[7]
Moss PE, Lyles BE, Stewart LV. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells[J]. Exp Cell Res, 2010, 316(20): 3478-3488.
[8]
Colin C, Salamone S, Grillier-Vuissoz I, et al. New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone dependent and hormone-independent breast cancer cell lines[J]. Breast Cancer Res Treat, 2010, 124(1): 101-110.
[9]
Panigrahy D, Singer S, Shen LQ, et al. PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis[J]. J Clin Invest, 2002, 110(7): 923-932.
[10]
Itakura E, Yamamoto H, Oda Y, et al. VEGF-C and VEGFR-3 in a series of lymphangiomas: is superficial lymphangioma a true lymphangioma [J]. Virchows Arch, 2009, 454(3): 317-325.
[11]
Breslin JW, Gaudreault N, Watson KD, et al. Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism[J]. Am J Physiol Heart Circ Physiol, 2007, 293(1): H709-H718.
[12]
Han FH, Li HM, Zheng DH, et al. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma[J]. Eur J Surg Oncol, 2010, 36(12): 1172-1179.
[13]
Saharinen P, Tammela T, Karkkainen MJ, et al. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation[J]. Trends Immunol, 2004, 25(7): 387-395.
[14]
Oliver G, Alitalo K. The lymphatic vasculature: recent progress and paradigms[J]. Annu Rev Cell Dev Biol, 2005, 21: 457-483.
